Surgery Partners Inc Stock Price, News & Analysis

Surgery Partners (NASDAQ:SGRY) announced the appointment of Dr. Patricia A. Maryland as an independent director, effective immediately. This addition expands the Board to nine members. Dr. Maryland brings 40 years of healthcare administration experience, most recently as executive vice president at Ascension, overseeing a vast network of hospitals and care facilities. She is recognized for her leadership in healthcare and has served on multiple boards. The company looks forward to leveraging her expertise to enhance patient care and drive growth.

Surgery Partners (NASDAQ:SGRY), a leader in outpatient surgical services, will announce its Q4 2020 results on March 10, 2021, before market opening. A conference call will follow at 8:30 a.m. ET, available for live access and replay. Interested parties can listen via the company's website, enhancing investor engagement. With over 180 locations nationwide, Surgery Partners continues to expand in the healthcare sector, emphasizing cost-effective surgical care and ancillary services.

Surgery Partners, Inc. (Nasdaq: SGRY) announced the pricing of a public offering of 7,500,000 shares of common stock at $30.25 per share, with expected gross proceeds of approximately $226.9 million. The offering includes a 30-day option for underwriters to purchase an additional 1,125,000 shares. Net proceeds will be used for general corporate purposes, including funding acquisitions and repaying debt. The offering is expected to close on February 1, 2021. J.P. Morgan Securities LLC and Jefferies LLC are the lead managers.

Surgery Partners (Nasdaq: SGRY) announced a public offering of 6,000,000 shares of common stock, all to be sold by the company. An additional 900,000 shares may be offered at the underwriters' discretion. The offering's completion is subject to market conditions. Proceeds will be used for general corporate purposes. J.P. Morgan and Jefferies serve as lead managers, with Barclays and others as joint managers. This offering follows a filed automatic shelf registration statement with the SEC, effective January 25, 2021.

Surgery Partners has announced its participation in the 2021 J.P. Morgan Healthcare Conference, providing full-year 2020 revenue guidance of approximately $1.86 billion and reaffirming Adjusted EBITDA guidance between $250 million and $260 million. For 2021, the company projects an Adjusted EBITDA of around $315 million, aiming to restore double-digit growth rates based on a pre-COVID baseline. However, these projections are subject to adjustments, and actual results may differ significantly due to customary financial closing procedures.

Surgery Partners (NASDAQ:SGRY) will present at the J.P. Morgan Healthcare Conference on January 11, 2021, at 2:50 p.m. ET. Executive Chairman Wayne S. DeVeydt, CEO Eric Evans, and CFO Tom Cowhey will represent the company. Interested investors can access a live webcast through the company's Investor Relations webpage, with a replay available later. Surgery Partners, headquartered in Brentwood, TN, operates over 180 locations across 30 states, focusing on high-quality, cost-effective surgical services since 2004.

Surgery Partners, a prominent surgical facility operator, announced that Wayne S. DeVeydt, Eric Evans, and Tom Cowhey will present at the 2nd Annual Wolfe Research Healthcare Conference on November 19, 2020, at 9:00 a.m. ET. Investors can listen to the live webcast on the company's Investor Relations webpage, with a replay available afterward. Founded in 2004 and headquartered in Brentwood, Tennessee, Surgery Partners operates over 180 locations across 30 states, focusing on delivering high-quality, cost-effective surgical care. For more information, visit www.surgerypartners.com.

Surgery Partners, Inc. (NASDAQ:SGRY) reported third-quarter results for 2020, revealing a 9.8% increase in revenues to $496.1 million and 9.9% growth in adjusted revenues to $503.9 million. However, the company faced a net loss of $71.6 million, a stark increase from the prior year's loss. Adjusted EBITDA rose 7% to $66.5 million, excluding CARES Act impacts. The company strategically closed non-core facilities, including a toxicology lab, while expanding its surgical services. Cash reserves stood at $450 million with ongoing monitoring of regulatory changes.

Surgery Partners, Inc. (NASDAQ:SGRY) will release its third quarter 2020 results before the market opens on November 4, 2020. The company will also host a conference call at 8:30 a.m. (ET) the same day, which can be accessed by dialing 1-877-451-6152 for domestic callers and 1-201-389-0879 for international participants. A replay of the call will be available until November 18, 2020.

Headquartered in Brentwood, Tennessee, Surgery Partners operates over 180 locations across 30 states, focusing on high-quality, cost-effective surgical and ancillary care services.